IL-23 Pathway Inhibition in IBD
Register Now And We Will Send You A Link.
May 6, 2021 @ 9:00 am - 12:30 pm EDT, and May 7, 2021 @ 9:00 am - 12:30 pm EDT
Watch presentations by our expert presenters and join interactive working sessions.
This two-half day, virtual educational event is organized for and by members of the Alimentiv Translational Research Consortium to understand the role of IL-23 pathway inhibition in IBD. The Symposium will bring together key stakeholders including gastroenterologists, basic & translational scientists, clinical pharmacologists, trialists and industry sponsors.
Agenda for May 6, 2021 (Virtual)
Markus Neurath, MD, Friedrich-Alexander-Universität (FAU), Erlangen-Nürnberg, Germany
Bruce Sands, MD, Mount Sinai, NY, USA
Brian Feagan, MD, Alimentiv Inc., Canada
Break (10 min)
Wouter de Jonge, PhD, Amsterdam UMC, Netherlands
Clara Abraham, MD, Yale, USA
Harry Sokol, MD, PhD, Sorbonne University, Inserm, France
Agenda for May 7, 2021 (Virtual)
Joseph Adedokun, MS, RPh, Johnson & Johnson, USA
Lili Cheng, PhD, Protagonist, USA
Maria Abreu, MD, University of Miami, USA
Break (15 min)
Instructions for Breakout Groups
Working groups to identify areas of translational research that can guide treatment strategies and accelerate further drug development
Working Group Presentation & General Discussion
Summary of Proposed Objectives